BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33916755)

  • 1. Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.
    Kellert M; Friedrichs JJ; Ullrich NA; Feinhals A; Tepper J; Lönnecke P; Hey-Hawkins E
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enlargement of a Modular System-Synthesis and Characterization of an
    Kellert M; Lönnecke P; Riedl B; Koebberling J; Hey-Hawkins E
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31509949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning a modular system - synthesis and characterisation of a boron-rich s-triazine-based carboxylic acid and amine bearing a galactopyranosyl moiety.
    Kellert M; Hoppenz P; Lönnecke P; Worm DJ; Riedl B; Koebberling J; Beck-Sickinger AG; Hey-Hawkins E
    Dalton Trans; 2020 Jan; 49(1):57-69. PubMed ID: 31808482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks.
    Kellert M; Worm DJ; Hoppenz P; Sárosi MB; Lönnecke P; Riedl B; Koebberling J; Beck-Sickinger AG; Hey-Hawkins E
    Dalton Trans; 2019 Aug; 48(29):10834-10844. PubMed ID: 31246208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry.
    Flieger S; Takagaki M; Kondo N; Lutz MR; Gupta Y; Ueda H; Sakurai Y; Moran G; Kempaiah P; Hosmane N; Suzuki M; Becker DP
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
    Sjöberg S; Carlsson J; Ghaneolhosseini H; Gedda L; Hartman T; Malmquist J; Naeslund C; Olsson P; Tjarks W
    J Neurooncol; 1997 May; 33(1-2):41-52. PubMed ID: 9151222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carborane-Containing Folic Acid
    Gruzdev DA; Telegina AA; Levit GL; Solovieva OI; Gusel'nikova TY; Razumov IA; Krasnov VP; Charushin VN
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-Soluble
    Nakagawa F; Kawashima H; Morita T; Nakamura H
    Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
    Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
    Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application.
    Achilli C; Grandi S; Ciana A; Guidetti GF; Malara A; Abbonante V; Cansolino L; Tomasi C; Balduini A; Fagnoni M; Merli D; Mustarelli P; Canobbio I; Balduini C; Minetti G
    Nanomedicine; 2014 Apr; 10(3):589-97. PubMed ID: 24161383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carborane-Containing Matrix Metalloprotease (MMP) Ligands as Candidates for Boron Neutron-Capture Therapy (BNCT).
    Lutz MR; Flieger S; Colorina A; Wozny J; Hosmane NS; Becker DP
    ChemMedChem; 2020 Oct; 15(20):1897-1908. PubMed ID: 32720425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT).
    Lamba M; Goswami A; Bandyopadhyay A
    Chem Commun (Camb); 2021 Jan; 57(7):827-839. PubMed ID: 33399147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
    Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
    Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
    Kawasaki R; Oshige A; Yamana K; Hirano H; Nishimura K; Miura Y; Yorioka R; Sanada Y; Bando K; Tabata A; Yasuhara K; Miyazaki Y; Shinoda W; Nishimura T; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Nagasaki T; Ikeda A
    Chemistry; 2023 Dec; 29(72):e202302486. PubMed ID: 37792507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment.
    Coghi P; Li J; Hosmane NS; Zhu Y
    Med Res Rev; 2023 Sep; 43(5):1809-1830. PubMed ID: 37102375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Couto M; Alamón C; García MF; Kovacs M; Trias E; Nievas S; Pozzi E; Curotto P; Thorp S; Dagrosa MA; Teixidor F; Viñas C; Cerecetto H
    Cells; 2020 Jun; 9(6):. PubMed ID: 32517054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.